Aurinia Pharmaceuticals Inc. (AUPH)
- Previous Close
8.15 - Open
8.11 - Bid 8.05 x 1300
- Ask 8.28 x 1300
- Day's Range
8.09 - 8.23 - 52 Week Range
5.11 - 10.67 - Volume
1,567,271 - Avg. Volume
1,445,473 - Market Cap (intraday)
1.107B - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
30.33 - EPS (TTM)
0.27 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.00
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
www.auriniapharma.comRecent News: AUPH
View More
Performance Overview: AUPH
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AUPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AUPH
View MoreValuation Measures
Market Cap
1.11B
Enterprise Value
871.51M
Trailing P/E
30.33
Forward P/E
14.47
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.80
Price/Book (mrq)
3.16
Enterprise Value/Revenue
3.52
Enterprise Value/EBITDA
13.23
Financial Highlights
Profitability and Income Statement
Profit Margin
16.11%
Return on Assets (ttm)
5.20%
Return on Equity (ttm)
11.23%
Revenue (ttm)
247.3M
Net Income Avi to Common (ttm)
39.84M
Diluted EPS (ttm)
0.27
Balance Sheet and Cash Flow
Total Cash (mrq)
312.59M
Total Debt/Equity (mrq)
22.25%
Levered Free Cash Flow (ttm)
47.49M
Research Analysis: AUPH
View MoreResearch Reports: AUPH
View MoreDaily – Vickers Top Insider Picks for 08/11/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 08/10/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 08/09/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 08/06/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.